Indications And Dose
Urinary frequency | Urinary urgency | Incontinence ▶BY MOUTH ▶Adult: Initially 7.5 mg once daily, increased if necessary to 15 mg after 2 weeks
PDF page 842
Loading InternPractice…
Drug reference
Urinary frequency | Urinary urgency | Incontinence ▶BY MOUTH ▶Adult: Initially 7.5 mg once daily, increased if necessary to 15 mg after 2 weeks
PDF page 842
The need for continuing therapy for urinary incontinence should be reviewed every 4–6 weeks until symptoms stabilise, and then every 6–12 months.
PDF page 843
→Appendix 1: darifenacin
PDF page 842
▶Common or very common Abdominal pain. dry eye. nasal dryness ▶Uncommon Asthenia. bladder pain. cough. diarrhoea. dyspnoea. erectile dysfunction. flatulence. hyperhidrosis. hypertension. increased risk of infection. injury. insomnia. oedema. oral ulceration. taste altered. thinking abnormal. urinary tract disorder
PDF pages 842, 843
Manufacturer advises avoid—toxicity in animal studies.
PDF page 843
Present in milk in animal studies— manufacturer advises caution.
PDF page 843
Manufacturer advises caution in moderate impairment; avoid in severe impairment (risk of increased exposure). Dose adjustments Manufacturer advises maximum 7.5 mg daily in moderate impairment.
PDF page 843
There can be variation in the licensing of different medicines containing the same drug. Modified-release tablet CAUTIONARY AND ADVISORY LABELS 3, 25 ▶Emselex (Merus Labs Luxco II S.a R.L.) Darifenacin (as Darifenacin hydrobromide) 7.5 mg Emselex 7.5mg modified-release tablets | 28 tablet P £25.48 DT = £25.48 Darifenacin (as Darifenacin hydrobromide) 15 mg Emselex 15mg modified-release tablets | 28 tablet P £25.48 DT = £25.48 eiiii F 820
PDF page 843
Initially 7.5 mg once daily, increased if necessary
First-line fragment. Read the complete Indications and Dose section above.
PDF page 842